Brief: Sio Gene Therapies Announces Successful Manufacture Of Three GMP Batches of AXO-Lenti-PD Gene Therapy for Parkinson’s Disease
11/11/2021 12:06
Nov 11 (Reuters) - Sio Gene Therapies Inc SIOX.O :
* SIO GENE THERAPIES ANNOUNCES SUCCESSFUL MANUFACTURE OF
THREE GMP
BATCHES OF AXO-LENTI-PD GENE THERAPY FOR PARKINSON'S DISEASE
Source text for Eikon: ID:nGNX7TRKt9
Further company coverage: SIOX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sio Gene Therapies
See all newsBrief: Sio Gene Therapies Inc - On March 14, Got Notice That Nasdaq Has Determined That Company's Common Stock Will Be Delisted From Nasdaq Capital Market
Brief: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Brief: Sio Gene Therapies Inc. Announces Board Approval Of Plan Of Complete Liquidation, Dissolution
Brief: Sio Gene Therapies Announces Second Quarter Financial Results
Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results